Abstract
This chapter provides an overview of community pharmacists, who are the most accessible healthcare professionals and can provide evaluation of medication adherence, patient counseling, insurance assessments, and mental health screenings with referral to mental health providers. Education in schools and colleges of pharmacy has focused on decreasing pharmacist stigma and negative images of people with mental disorders and increasing the comfort level of the pharmacist for interacting with patients through the use of motivational interviewing and shared decision-making. Pharmacists are uniquely positioned to fill the gap in available mental health providers, both in the community pharmacy and clinical practice setting.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amin, K., Farley, J. F., Maciejewski, M. L., & Domino, M. E. (2017). Effect of Medicaid policy changes on medication adherence: Differences by baseline adherence. Journal of Managed Care & Specialty Pharmacy, 23(3), 337–345. https://doi.org/10.18553/jmcp.2017.23.3.337
Arnold, M. E., Buys, L., & Fullas, F. (2015). Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate. American Journal of Health-System Pharmacy, 72(11 Suppl 1), S36–S42. https://doi.org/10.2146/sp150011
Benson, C. J., Joshi, K., Lapane, K. L., & Fastenau, J. (2015). Evaluation of a comprehensive information and assistance program for patients with schizophrenia treated with long-acting injectable antipsychotics. Current Medical Research and Opinion, 31(7), 1437–1448. https://doi.org/10.1185/03007995.2015.1050365
Calogero, S., & Caley, C. F. (2017). Supporting patients with mental illness: Deconstructing barriers to community pharmacist access. Journal of the American Pharmacists Association, 57(2), 248–255. https://doi.org/10.1016/j.japh.2016.12.066
Cavanaugh, J. J., Lindsey, K. N., Shilliday, B. B., & Ratner, S. P. (2015). Pharmacist-coordinated multidisciplinary hospital follow-up visits improve patient outcomes. Journal of Managed Care & Specialty Pharmacy, 21(3), 256–260. https://doi.org/10.18553/jmcp.2015.21.3.256
Dalton, K., & Byrne, S. (2017). Role of the pharmacist in reducing healthcare costs: Current insights. Integrated Pharmacy Research & Practice, 6, 37–46. https://doi.org/10.2147/iprp.S108047
Di Lorenzo, R., Galliani, A., Guicciardi, A., Landi, G., & Ferri, P. (2014). A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services. Neuropsychiatric Disease and Treatment, 10, 1479–1488. https://doi.org/10.2147/ndt.S65896
Doshi, J. A., Li, P., Desai, S., & Marcus, S. C. (2017). Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Journal of Medical Economics, 20(12), 1252–1260. https://doi.org/10.1080/13696998.2017.1365720
Gallagher, J., McCarthy, S., & Byrne, S. (2014). Economic evaluations of clinical pharmacist interventions on hospital inpatients: A systematic review of recent literature. International Journal of Clinical Pharmacy, 36(6), 1101–1114. https://doi.org/10.1007/s11096-014-0008-9
Gilmore, V., Efird, L., Fu, D., LeBlanc, Y., Nesbit, T., & Swarthout, M. (2015). Implementation of transitions-of-care services through acute care and outpatient pharmacy collaboration. American Journal of Health-System Pharmacy, 72(9), 737–744. https://doi.org/10.2146/ajhp140504
Grim, K., Rosenberg, D., Svedberg, P., & Schon, U. K. (2016). Shared decision-making in mental health care-a user perspective on decisional needs in community-based services. International Journal of Qualitative Studies on Health and Well-Being, 11, 30563. https://doi.org/10.3402/qhw.v11.30563
Larrison, C. R., Hack-Ritzo, S., Koerner, B. D., Schoppelrey, S. L., Ackerson, B. J., & Korr, W. S. (2011). State budget cuts, health care reform, and a crisis in rural community mental health agencies. Psychiatric Services, 62(11), 1255–1257. https://doi.org/10.1176/ps.62.11.pss6211_1255
Lê Cook, B., Doksum, T., Chen, C. N., Carle, A., & Alegria, M. (2013). The role of provider supply and organization in reducing racial/ethnic disparities in mental health care in the U.S. Social Science & Medicine, 84, 102–109. https://doi.org/10.1016/j.socscimed.2013.02.006
Luetsch, K., & Burrows, J. (2018). From transitions to transformation: A study of pharmacists developing patient-centered communication skills. Research in Social & Administrative Pharmacy, 14(7), 686–694. https://doi.org/10.1016/j.sapharm.2017.08.003
Marcus, S. C., Zummo, J., Pettit, A. R., Stoddard, J., & Doshi, J. A. (2015). Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge. Journal of Managed Care & Specialty Pharmacy, 21(9), 754–768. https://doi.org/10.18553/jmcp.2015.21.9.754
McGovern, M. P., Lambert-Harris, C., Gotham, H. J., Claus, R. E., & Xie, H. (2014). Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems. Administration and Policy in Mental Health, 41(2), 205–214. https://doi.org/10.1007/s10488-012-0449-1
Morant, N., Kaminskiy, E., & Ramon, S. (2016). Shared decision making for psychiatric medication management: Beyond the micro-social. Health Expectations, 19(5), 1002–1014. https://doi.org/10.1111/hex.12392
Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C. M., & Bero, L. (2010). Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. The Cochrane Database of Systematic Reviews, 7, Cd000336. https://doi.org/10.1002/14651858.CD000336.pub2
Ovsag, K., Hydery, S., & Mousa, S. A. (2008). Preferred drug lists: Potential impact on healthcare economics. Vascular Health and Risk Management, 4(2), 403–413.
Padwa, H., Guerrero, E. G., Braslow, J. T., & Fenwick, K. M. (2015). Barriers to serving clients with co-occurring disorders in a transformed mental health system. Psychiatric Services, 66(5), 547–550. https://doi.org/10.1176/appi.ps.201400190
Phokeo, V., Sproule, B., & Raman-Wilms, L. (2004). Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatric Services, 55(12), 1434–1436. https://doi.org/10.1176/appi.ps.55.12.1434
Ramalho de Oliveira, D., Brummel, A. R., & Miller, D. B. (2010). Medication therapy management: 10 years of experience in a large integrated health care system. Journal of Managed Care Pharmacy, 16(3), 185–195. https://doi.org/10.18553/jmcp.2010.16.3.185
Richardson, T. E., O’Reilly, C. L., & Chen, T. F. (2014). A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. International Journal of Clinical Pharmacy, 36(2), 222–232. https://doi.org/10.1007/s11096-013-9900-y
Ridley, D. B., & Axelsen, K. J. (2006). Impact of Medicaid preferred drug lists on therapeutic adherence. PharmacoEconomics, 24(Suppl 3), 65–78.
Rubio-Valera, M., Chen, T. F., & O’Reilly, C. L. (2014). New roles for pharmacists in community mental health care: A narrative review. International Journal of Environmental Research and Public Health, 11(10), 10967–10990. https://doi.org/10.3390/ijerph111010967
Salvo, M. C., & Cannon-Breland, M. L. (2015). Motivational interviewing for medication adherence. Journal of the American Pharmacists Association, 55(4), e354–e361.; quiz e362-353. https://doi.org/10.1331/JAPhA.2015.15532
The Center for Consumer Information & Insurance Oversight. (2018). The mental health parity and addiction equality act (MHPAEA). [web page]. Baltimore, MD: Centers for Medicare & Medicaid Services. https://www.cms.gov/cciio/programs-and-initiatives/other-insurance-protections/mhpaea_factsheet.html
Wright, W. A., Gorman, J. M., Odorzynski, M., Peterson, M. J., & Clayton, C. (2016). Integrated pharmacies at community mental health centers: Medication adherence and outcomes. Journal of Managed Care & Specialty Pharmacy, 22(11), 1330–1336. https://doi.org/10.18553/jmcp.2016.16004
Younas, M., Bradley, E., Holmes, N., Sud, D., & Maidment, I. D. (2016). Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness. International Journal of Clinical Pharmacy, 38(5), 1191–1199. https://doi.org/10.1007/s11096-016-0352-z
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ott, C.A. (2020). Pharmacy Services in Behavioral Health. In: Levin, B.L., Hanson, A. (eds) Foundations of Behavioral Health. Springer, Cham. https://doi.org/10.1007/978-3-030-18435-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-18435-3_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18433-9
Online ISBN: 978-3-030-18435-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)